BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 4084295)

  • 1. Activation of rat liver glucocorticoid receptor bound to the antiglucocorticoid RU38486.
    Agarwal MK; Lombardo G; Eliezer N; Moudgil VK
    Biochem Biophys Res Commun; 1985 Dec; 133(2):745-52. PubMed ID: 4084295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RU 486 stabilizes a high molecular weight form of the glucocorticoid receptor containing the 90K non-steroid binding protein in intact thymus cells.
    Lefebvre P; Formstecher P; Richard C; Dautrevaux M
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1221-9. PubMed ID: 3342067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical characterization of the activated and non-activated forms of the glucocorticoid-receptor complex bound to the steroid antagonist [3H]RU 486.
    Sablonniere B; Danze PM; Formstecher P; Lefebvre P; Dautrevaux M
    J Steroid Biochem; 1986 Nov; 25(5A):605-14. PubMed ID: 3795940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the glucocorticoid receptor binding subunit with the 90K nonsteroid-binding component is stabilized by both steroidal and nonsteroidal antiglucocorticoids in intact cells.
    Lefebvre P; Danze PM; Sablonniere B; Richard C; Formstecher P; Dautrevaux M
    Biochemistry; 1988 Dec; 27(26):9186-94. PubMed ID: 3242623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characteristics of the interaction of the glucocorticoid antagonist RU38486 with glucocorticoid receptors in vitro, and the role of molybdate.
    Bell PA; Weatherill PJ
    J Steroid Biochem; 1986 Oct; 25(4):473-81. PubMed ID: 3773520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic glucocorticoid receptor behaves differently when its hormone binding site is occupied by agonist (triamcinolone acetonide) or antagonist (RU486) steroid ligands.
    Moudgil VK; Gunda M
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1239-47. PubMed ID: 1996987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vivo activation of triamcinolone acetonide- and RU 38486-receptor complexes in the CEM-C7 and IM-9 human leukemic cell lines.
    Schmidt TJ
    Cancer Res; 1989 Aug; 49(16):4390-5. PubMed ID: 2743328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A correlative study of RU38486 biopotency and competition with [3H]dexamethasone for receptors in the rat central nervous system.
    Allen BD; Sutanto W; Jones MT
    J Steroid Biochem; 1988; 30(1-6):411-5. PubMed ID: 3386269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activation of rat cardiac glucocorticoid antagonist- versus agonist-receptor complexes.
    Schmidt TJ; Diehl EE
    Biochim Biophys Acta; 1988 Jun; 970(2):212-21. PubMed ID: 3382699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
    Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
    Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the interaction of RU 486 and ketoconazole with the second binding site of the glucocorticoid receptor.
    Svec F
    Endocrinology; 1988 Oct; 123(4):1902-6. PubMed ID: 3416819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RU 486 stabilizes the glucocorticoid receptor in a non-transformed high molecular weight form in intact thymus cells under physiological conditions.
    Formstecher P; Lefebvre P; Dautrevaux M
    J Steroid Biochem; 1988 Oct; 31(4B):607-12. PubMed ID: 3199809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of specific transcription and DNA binding studies suggest that in vitro transformed RU 486-glucocorticosteroid receptor complexes display agonist activity.
    Schweizer-Groyer G; Cadepond F; Groyer A; Idziorek T; Mariller M; Baulieu EE
    J Steroid Biochem; 1988; 30(1-6):291-4. PubMed ID: 3386256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for differences in the steroid binding domains of the glucocorticoid receptor versus the idiotype antibody.
    Agarwal MK; Cayanis E
    Biochem Biophys Res Commun; 1986 Apr; 136(2):470-5. PubMed ID: 3707584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of rat liver glucocorticoid receptor with a newly synthesized antisteroid ZK98299.
    Zakula Z; Moudgil VK
    Biochim Biophys Acta; 1991 Apr; 1092(2):188-95. PubMed ID: 2018785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of antiglucocorticoid RU 486 with rat kidney glucocorticoid receptor.
    Kalimi MY; Agarwal MK
    Biochem Biophys Res Commun; 1988 May; 153(1):365-71. PubMed ID: 3377791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transformed glucocorticoid receptor has a lower steroid-binding affinity than the nontransformed receptor.
    Nemoto T; Ohara-Nemoto Y; Denis M; Gustafsson JA
    Biochemistry; 1990 Feb; 29(7):1880-6. PubMed ID: 2184891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic study of the nuclear transfer of the antiglucocorticoid compound RU38486 in mouse tissues.
    Coutard M; Duval D
    J Steroid Biochem; 1985 Sep; 23(3):291-7. PubMed ID: 4046603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activation and DNA binding affinity of human lymphoid (CEM-C7) cytoplasmic receptors labeled with the antiglucocorticoid RU 38486.
    Schmidt TJ
    J Steroid Biochem; 1986 Apr; 24(4):853-63. PubMed ID: 2871233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microheterogeneity of agonist and antagonist glucocorticoid receptor complexes detected by isoelectric focusing and modifications induced by receptor activation.
    Danze PM; Formstecher P; Richard C; Dautrevaux M
    Biochim Biophys Acta; 1987 Jan; 927(1):129-38. PubMed ID: 3790617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.